Human immune cell mobilization during exercise: effect of IL‐6 receptor blockade. Issue 12 (16th October 2020)

• Record Type: Journal Article
• Authors: Bay, Marie Lund; Heywood, Sarah; Wedell‐Neergaard, Anne‐Sophie; Schauer, Tim; Lehrskov, Louise Lang; Christensen, Regitse Højgaard; Legård, Grit Elster; Jensen, Peter Østrup; Krogh‐Madsen, Rikke; Ellingsgaard, Helga
• Is Part Of: Experimental physiology. Volume 105:Issue 12(2020:Dec.)
• Page Start: 2086
• Page End: 2098
• Publication Date: 2020-10-16
• Subjects: dendritic cells -- exercise -- interleukin‐6 -- NK cells -- tocilizumab; Physiology, Experimental -- Periodicals; 571.0724
• DOI: 10.1113/EP088864
• Languages: English
• ISSNs: 0958-0670

Abstract

Abstract : New Findings: What is the central question of this study? Does blockade of the IL‐6 receptor by tocilizumab inhibit immune cell mobilization to the blood stream in humans during an acute bout of exercise? What is the main finding and its importance? Blockade of IL‐6 receptor signalling by tocilizumab attenuates mobilization of NK cells and dendritic cells to the blood stream during exercise. This implies an inhibitory effect of tocilizumab on the innate immune response to physical stress, which could be considered in clinical settings. Abstract: Immune cells are recruited from their storage organs and the endothelial walls to the blood stream in response to physiological stress. This is essential for the recognition and clearing of infected, transformed or damaged cells. One of the most potent stimuli to recruit immune cells to the circulation is exercise. Accordingly, exercise has proven beneficial in disease settings, such as cancer and diabetes. Interleukin‐6 (IL‐6) is released from contracting skeletal muscle in response to exercise, and rodent studies have established a link between exercise‐induced IL‐6 and recruitment of natural killer (NK) cells. Whether exercise‐induced IL‐6 is involved in regulating NK cell mobilization in humans is unclear. This study explored the effect of IL‐6 receptor blockade on immune cell mobilization during an acute bout of exercise in humans. In a randomized, placebo‐controlled clinical study, abdominally obese humans receiving placebo infusions or tocilizumab infusions performed an acute bout of exercise before and after the intervention. Immune cell recruitment was measured by flow cytometry. IL‐6 receptor blockade attenuated the increase of NK cells by 53% (mean difference −0.49 (95% CI: −0.89 to −0.08) × 10 9 cells L −1, P < 0.001) and dendritic cells by 66% (mean difference −0.14 (95% CI: −0.28 to 0.010) × 10 9 cells L −1, P < 0.001) induced by an acute bout of exercises. No changes were observed for T cells, monocytes and neutrophils. Treatments which interact with the exercise‐mediated immune surveillance provide relevant clinical information in pursuing the 'exercise as medicine' concept. Abstract :